Cargando…
Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML
Acute myeloid leukemia (AML) remains an elusive disease to treat, let alone cure, even after highly intensive therapies such as stem cell transplants. Adoptive cell therapeutic strategies based on conventional alpha beta (αβ)T cells are an active area of research in myeloid neoplasms given their rem...
Autores principales: | Kent, Andrew, Crump, Lyndsey S., Davila, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465706/ https://www.ncbi.nlm.nih.gov/pubmed/37654497 http://dx.doi.org/10.3389/fimmu.2023.1202950 |
Ejemplares similares
-
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
por: Li, Yan-Ruide, et al.
Publicado: (2021) -
Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020) -
miR-150 regulates the development of NK and iNKT cells
por: Bezman, Natalie A., et al.
Publicado: (2011) -
Reduction of Peripheral Blood iNKT and γδT Cells in Patients With Parkinson's Disease: An Observational Study
por: Zhou, Chao, et al.
Publicado: (2020) -
Adoptive Immunotherapy With Engineered iNKT Cells to Target Cancer Cells and the Suppressive Microenvironment
por: Delfanti, Gloria, et al.
Publicado: (2022)